Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Medical Devices & Technology (Technology)
*Driving Forces: Telemedicine,Telehealth, Mobile Health, mHealth, Virtual, Digital Health, DTx (Digital Therapeutics)
*Driving Forces: Telemedicine,Telehealth, mHealth & Home Health (Sectors)
*Driving Forces: Primary Care, Chronic Disease, Wellness, Weight Loss, Obesity, Coordinated Care
*Pioneers: Diabetes
*Pioneers: Diabetes (Research Centers & Organizations)
JDRF (Juvenile Diabetes Research Foundation International)

Organization & Developments: JDRF

Parents

*Artificial Pancreas
2010: Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals Partner to Investigate Metreleptin as Potential Therapy to Improve Blood Glucose Control in Type 1 Diabetes (2010)
2010: Juvenile Diabetes Research Foundation's Artificial Pancreas Project, Pioneers:Tissue Engineering & Regenerative Medicine
2011: Has awarded $75 million to 32 companies that are developing entirely new approaches to combating Type 1 diabetes (2011)
2011: Industry Discovery and Development Partnership Program
2011: The Juvenile Diabetes Research Foundation and Selecta Biosciences, Inc. Enter Research Collaboration for Vaccines for Type 1 Diabetes (2011)
2012: Juvenile Diabetes Research Foundation, Helmsley Charitable Trust Partner With Medtronic (2012)
2013: Insulin pump maker Tandem craves $123M in upsized IPO (2013)
2016: JDRF Awards $1.14 Million for New Glucose Monitoring, Infusion Device
2017: IBM, JDRF to unravel Type 1 diabetes risk factors with machine learning
JDRF Center for Translational Research
Juvenile Diabetes Foundation International 120 Wall Street, 19th Floor New York, NY 10005-4001
Leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas.